1. Home
  2. RANI vs RFAM Comparison

RANI vs RFAM Comparison

Compare RANI & RFAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

HOLD

Current Price

$0.96

Market Cap

126.8M

Sector

Health Care

ML Signal

HOLD

RFAM

RF Acquisition Corp III Ordinary Shares

N/A

Current Price

$9.84

Market Cap

137.1M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
RANI
RFAM
Founded
2012
2025
Country
United States
Singapore
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
126.8M
137.1M
IPO Year
2021
2026

Fundamental Metrics

Financial Performance
Metric
RANI
RFAM
Price
$0.96
$9.84
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$7.50
N/A
AVG Volume (30 Days)
676.4K
9.3K
Earning Date
05-07-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
57.14
N/A
EPS
N/A
N/A
Revenue
$1,633,000.00
N/A
Revenue This Year
$274.77
N/A
Revenue Next Year
$79.44
N/A
P/E Ratio
N/A
N/A
Revenue Growth
58.85
N/A
52 Week Low
$0.39
$9.77
52 Week High
$3.87
$9.94

Technical Indicators

Market Signals
Indicator
RANI
RFAM
Relative Strength Index (RSI) 52.50 48.93
Support Level $0.46 $9.81
Resistance Level $1.05 $9.90
Average True Range (ATR) 0.07 0.01
MACD 0.02 0.00
Stochastic Oscillator 61.01 33.33

Price Performance

Historical Comparison
RANI
RFAM

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

About RFAM RF Acquisition Corp III Ordinary Shares

RF Acquisition Corp III is a blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination.

Share on Social Networks: